Levi & Korsinsky notifies investors that it has commenced an investigation into Arvinas, Inc. (NASDAQ: ARVN) concerning potential violations of the federal securities laws.
On May 1, 2025, Arvinas issued a press release announcing a re-prioritization of its vepdegestrant development plan and research portfolio. Management also announced it was initiating cost reductions, including cutting approximately one-third of its workforce. Following this news, ARVN’s stock price fell by $2.39 per share, or approximately 25% to close at $7.23 per share.
If you suffered a loss on your Arvinas securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure





